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Abstract
The biological activity and solubility of compounds are influenced by its chemical structure. These properties can be
improved by substituting alkyl, alkoxy, and/or haloalkane in the parent skeleton. In this research, the synthesis of 3-(7bromoheptyl)-2-methyl-5-methoxy-1,4-benzoquinone (3a) and 3-(10-bromodecyl)-2-methyl-5-methoxy-1,4-benzoquinone
(3b) was achieved through the decarboxylation reaction. The solubility and biological activity of 3a and 3b were
compared with that of thymoquinone (TQ), which acts as an anti-inflammatory agent. Compounds 3a and 3b were
successfully synthesized and analyzed using Fourier Transform Infra-Red (FTIR) and Nuclear Magnetic Resonance
(NMR). The FTIR spectrum showed the increasing intensity of C-H sp3 and the absorption of C-Br because of the
presence of the bromoheptyl and bromodecyl substituents. 1H-NMR showed the prominent chemical shift of olefinic
methylene at δ 1.29–3.40 ppm. The solubility test showed the differences in the partition coefficient (log P) of 3a and
3b in the n-octanol/water system. The log P values of 3a and 3b are higher than those of TQ, indicating that methoxy,
bromoheptyl, and bromodecyl support the increase in solubility. Biological activity test using the in silico approach
showed that 3a and 3b have a higher tendency to bind with the translocator protein (TSPO) macromolecule than the
phosphatase and tensin homolog (PTEN) macromolecule. The binding interactions of TSPO-3a and TSPO-3b, similar
to that of TSPO-TQ, showed that both synthesized compounds have comparable activity. The binding energy of TSPO3a is lower than that of TSPO-3b, indicating that 3a has a higher activity for anti-inflammatory drug candidates than 3b.
Keywords: 1,4-benzoquinone, bromoalkylation, partition coefficient, thymoquinone, lipophilicity

quinone derivatives, including alkylated cationic TQ,
such as SkQT1 and SkQ1, have also been reported [6].
SkQT1 and SkQ1 are potential antioxidants that target
mitochondria because the inner membrane of
mitochondria is negatively charged. Recently, the
synthesis of benzoquinone having bromoalkyl
substituents, such as 3-(10-bromodecyl)-5-isopropyl-2methyl-1,4-benzoquinone [7], 5-(7-bromoheptyl)-2,3dimethyl-1,4-benzoquinone [8], 2-(5-bromoamyl)-3,5dimethyl-1,4-benzoquinone [9], and phosphonium-1,4benzoquinone derivatives, have been reported [10]
(Figure 1). In silico analysis of these compounds
showed that the bromoheptyl (C7) and bromodesyl
(C10) substituents effectively increased solubility in the
n-octanol/water system. By contrast, methoxy (–OMe)
attached to 5-methyl-1,4-benzoquinone without
bromoalkyl substituent resulted in decreased solubility
[11]. In this research, the synthesis of 1,4-benzoquinone
derivatives with methoxy and bromoalkyl substituents is
proposed to increase the biological activity and
solubility compounds.

Introduction
Naturally occurring quinones, such as 2-isopropyl-5methyl-1,4-benzoquinone, also known as thymoquinone
(TQ), are an active constituent of Nigella sativa seed oil
[1]. The therapeutic effect of N. sativa seed oil with TQ
on the treatment of several chronic diseases, such as
cancer and inflammatory disorders, has been
investigated [2,3]. However, pharmacokinetic studies of
TQ by oral administration in an animal model showed
rapid elimination and relatively slow absorption [4]. To
improve the bioavailability and biological activity of
quinone-based drugs, structure modification by inserting
polar and/or nonpolar functional groups, such as
methoxy and bromoalkyl substituents, has become a
promising and interesting subject.
Quinone-containing alkylating agents, such as mitomycin
C, also known as “bioreductive alkylating drugs,” refer
to drugs with an electrophilic substituent to bind
covalently to cellular macromolecules [5]. Novel
13

March 2021  Vol. 25  No. 1

14 Ulfa, et al.

Figure 1. Examples of Quinone-based Derivatives

First, the solubility of drug candidate compounds is
considered. Then, the biological activity of drug
candidate compounds is evaluated using in silico
molecular docking between macromolecule (proteins or
enzymes) and ligand [12]. The binding of compounds
with a specific receptor is calculated for the free energies
(∆Go) of protein–ligand complexes, the inhibitory
constant (Ki), and the half-maximal inhibitory
concentration (IC50). The data of many drug candidates
have been analyzed on the basis of the Ki value instead
of the IC50 value because Ki is an intrinsic and
thermodynamic quantity that depends on the enzyme
and inhibitor. By contrast, the IC50 value depends on
concentrations of the target macromolecule, inhibitor,
and ligand, along with other experimental conditions
[13]. The target macromolecule for in silico design is
close to human disease and binds to a small molecule to
yield a function [14]. In this research, we introduced the
translocator protein (TSPO) and phosphatase and tensin
homolog (PTEN). TSPO is an 18 kDa transmembrane
protein primarily found in the outer mitochondrial
membrane, which mainly suppresses inflammatory
disorders. TSPO is a prospective protein model because
its interaction with the endogenous and exogenous
ligands, i.e., having the methoxy substituent, has rarely
been reported. The families of heterocyclic molecules
with at least one nitrogen and/or carbonyl group (C=O)
responds to TSPO [15]. Another macromolecule is
PTEN, which induces the apoptosis of cancer cells [16].
In summary, we highlighted the synthesis of 3-(7bromoheptyl)-2-methyl-5-methoxy-1,4-benzoquinone
(3a) and 3-(10-bromodecyl)-2-methyl-5-methoxy-1,4benzoquinone (3b). Solubility was evaluated using the
shake-flask method. Biological activity was evaluated
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using in silico molecular docking, with TSPO and
PTEN as macromolecules.

Materials and Methods
Materials. 2-Methyl-1,4-benzoquinone (1) was obtained
from Sigma-Aldrich (Singapore) and directly used for
the synthesis of 2-methyl-5-methoxy-1,4-benzoquinone
(2). Other chemicals, such as 8-bromooctanoic acid
(C8H15BrO2), 11-bromoundecanoic acid (C11H21BrO2),
and ammonium persulfate ((NH4)2S2O4), were also
purchased from Sigma-Aldrich (Singapore). Silver
nitrate (AgNO3) and sodium sulfate (Na2SO4) were
obtained from Merck (Singapore) and used as drying
agents. The solvents acetonitrile, ethyl acetate, diethyl
ether, and n-hexane supplied by Merck (Singapore)
were of analytical grade.
Instrumentations. The UV–Visible Shimadzu 1600,
FTIR Shimadzu 8400S, HPLC Shimadzu LC-20AD
Prominence with FID detector, and NMR spectroscopy
JEOL ECS400 were used in this research.
Synthesis of the 5-methoxy-1,4-benzoquinone
derivatives 3a and 3b. 2-Methyl-5-methoxy-1,4benzoquinone (2) was prepared by substitution of
methoxy into 2-methyl-1,4-benzoquinone (1) using
methanol as a nucleophile (Scheme 1) according to
previous research [11]. Compound 2 was obtained as a
yellow needle crystal and directly used for the synthesis
of 3a and 3b. The synthesis of 3a and 3b was achieved
through the decarboxylation reaction as follows [8]:
Compound 2 (2.0 mmol, 304 mg) was combined with 8bromooctanoic acid (2.1 mmol, 468 mg) to synthesize
3a or 11-bromoundecanoic acid (2.1 mmol, 556 mg) to
March 2021  Vol. 25  No. 1
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synthesize 3b. AgNO3 (1.0 mmol, 169 mg) and
acetonitrile/H2O (2:1) were added and stirred at a
temperature of 80 °C. Afterward, (NH4)2S2O8 (2 mmol,
456 mg) in 3 mL H2O was added dropwise, stirred for
60–90 min, and maintained at temperatures of 70 °C to
80 °C. The obtained mixture was extracted with diethyl
ether. The organic phase was separated and dried over
Na2SO4. The excess solvent was evaporated to obtain
the brownish red liquid product. The crude product was
purified by SiO2 column chromatography using nhexane/chloroform (6:4 ratio (v/v)). 3a and 3b were
characterized using FTIR Shimadzu 8400S, UV–Visible
Shimadzu 1600, and 1H-NMR 400 MHz in CDCl3 and
TMS as the internal standard. Physical properties of the
synthesis compounds: 3-(7-bromoheptyl)-2-methyl-5methoxy-1,4-benzoquinone (3a): yellow oil (20 mg;
1.41%). Thin-layer chromatography (TLC) analysis
using n-hexane/ethyl acetate (7:3) yielded Rf = 0.62;
UV–Vis analysis yielded max = 264 nm. FTIR analysis
(cm−1): 2,925 (C-H sp3), 1,728 (C=O), 1,649 (C=C),
1,460 (CH2), 1,274 (C-O), 565 (C-Br); 1H-NMR (400
MHz, CDCl3) δ 8.09 (s, 1H, H-1), 3.91 (s, 3H, –OCH3),
3.40 (t, 2H, J = 6.4 Hz, H-3), 2.41 (t, 2H, J = 7.1 Hz, H4), 2.02 (s, 3H, H-5), 1.85 (m, 2H, J = 6.4, 7.1 Hz, H-6),
1.56–1.28 (d, 8H, J = 6.4, 7.1 Hz, H-7). 3-(10bromodecyl)-2-methyl-5-methoxy-1,4-benzoquinone (3b):
yellow oil (10 mg; 0.76%). TLC analysis using nhexane/ethyl acetate (7:3) yielded Rf = 0.58; UV–Vis
analysis yielded max = 260 nm. FTIR analysis (cm−1):
2,854 (C-H sp3), 1,647 (C=O), 1,460 (C=C), 1,226 (CO), 636 (C-Br); 1H-NMR (400 MHz, CDCl3) δ 8.09 (s,
1H, H-1), 3.91 (s, 3H, –OCH3), 3.40 (t, 2H, J = 6.4 Hz,
H-3), 2.41 (t, 2H, J = 6.8 Hz, H-4), 2.02 (s, 3H, H-5),
1.85 (m, 2H, J = 6.4 Hz, H-6), 1.38–1.28 (d, 14H, J =
6.4 Hz, H-7).
Solubility test of 3a and 3b in the n-octanol/water
system. Before the solubility test, the hydrophobic and
hydrophilic phases were prepared according to the
following procedure [17]: A phosphate buffer solution
(pH 7.4) was prepared by mixing 67 mL NaH2PO4·H2O
(0.1 M) with 330 mL Na2HPO4 (0.1 M). This solution
was designated as the water system. The water system
was saturated with n-octanol to obtain the hydrophilic
phase. Meanwhile, the hydrophobic phase was prepared
by saturating n-octanol with the water system. Both
solutions were mixed for at least 24 h and then
separated. Compounds 3a, 3b, and TQ were dissolved
in n-octanol (10 mM). Then, n-octanol containing the
compounds was mixed with water in 3:7 (v/v) partition
for 1 h at room temperature using an orbital shaker.
Afterward, n-octanol and water were separated. HPLC
analysis of water and n-octanol was performed by
injecting 2 µL of each partition with 0.5 mL/min flow
rate at 37 °C. The distribution of each compound in noctanol and water was calculated using Eq. 1, where
Coctanol and Cwater are the total drug concentration in noctanol and water. The total drug concentration was
Makara J. Sci.

derived from the peak areas of 3a and 3b in n-octanol
(Ao) and water (Aw) divided by the volumes of the noctanol (Vo) and water (Vw) partitions.
(1)

Biological evaluation of 3a and 3b using the in silico
approach. The biological evaluation of 3a and 3b was
conducted using AutoDock4. The ligand structures of
3a, 3b, and TQ were optimized using HyperChem and
saved in.pdb format. The TSPO and PTEN
macromolecule models were downloaded from
www.rcsb.org and saved in.pdb format. Both water and
external
ligands
were
removed
from
the
macromolecules. The docking process consists of two
main steps, namely, running AutoGrid (format
conversion into.gpf) and running AutoDock (format
conversion into.dpf). The AutoDock parameter was
used to calculate the van der Waals and electrostatic
terms. Docking simulations were performed using the
Lamarckian genetic algorithm. The grid boxes for the
macromolecules used in this research were designed
using AutoGrid4, with TSPO box dimensions for 3a,
3b, and TQ of x = 32.778, y = −17.093, and z = 69.101
and PTEN box dimensions for 3a, 3b, and TQ of x =
268.883, y = 19.827, and z = 47.339. AutoDock4 was
run to determine the minimum energy for each bond.
The results of binding interactions (Ki), minimum
energy, and amino acid and ligand interactions were
analyzed using the Discovery Studio Visualizer [8].

Results and Discussion
The synthesis of 3a and 3b was achieved through the
decarboxylation reaction using 8-bromooctanoic acid
and 11-bromoundecanoic acid. The synthesis routes are
shown in Scheme 1. Compounds 3a and 3b were
obtained as brownish oil with 1.41% and 0.76% yields,
respectively. Compared with that of a similar reaction,
the product yields of 3a and 3b through the
decarboxylation reaction were relatively low. The
presence of methoxy (–OMe) at the meta-position
probably suppressed the alkylation reaction [18]. The
synthesis strategy should be improved to increase the
reaction yield by prolonging the reaction time and/or
increasing the reaction temperature.
TLC analysis showed that 3a and 3b have a similar
retardation factor (Rf). Compared with 2-methyl-5methoxy-1,4-benzoquinone (2), both alkylation products
3a and 3b showed a larger Rf, which indicates that the
insertion of the alkyl group into 1,4-benzoquinone
decreased the polarity of the compound. Additional
analysis using UV–Vis showed that the introduction of
alkyl increased the wavelengths of 3a and 3b, resulting
in a redshift. FTIR analysis of 3a, 3b, and 2 (Figure 2)
March 2021  Vol. 25  No. 1
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Scheme 1. Synthesis Overview

Figure 2. FTIR spectra of 3a (left) and 3b (right)

showed a significant difference between these
compounds. The increase in the intensity of the C-H sp3
peak at 2,924 cm−1 (3a) and 2,854 cm−1 (3b) was due to
the substitution of alkyl in benzoquinone. The new
peaks at 646 and 636 cm−1 corresponded to C-Br in
compounds 3a and 3b, respectively. The overall
analysis indicated that the addition of alkyl substitution
to the synthesis process has been successful [8].
The structures of the quinone skeletons of 3a and 3b are
similar; hence, only compound 3a is discussed in detail
as follows (see Table 1, Figure 3): The presence of a
singlet peak at δ 8.09 ppm (1H, s) indicates that one
proton attached to the benzoquinone ring. From this
pattern, it is assumed that the alkylation reaction only
replaces one proton at C-3 or C-6. Further analysis
showed the proton appears in the high-field region at δ
0.85–2.41 ppm, which indicates an aliphatic proton. The
peak at δ 2.41 ppm (2H, br) corresponds to the
methylene proton that directly attached to the quinone
ring with the sequence Ar–CH2–R, and the peak at δ
1.85 ppm (2H, m) corresponds to the methylene proton
that directly attached to the quinone ring with the
sequence R–CH2–R. The other multiplet at 1.56–1.28
(8H, m) corresponds to aliphatic methylene in saturated
alkane. The terminal methylene, which is directly
attached to bromine R–CH2–Br, is observed at δ 3.40
ppm (t, 2H, J = 6.4 Hz). The methyl proton shifted to
1.84 ppm (3H, s), and methoxy was detected as a sharp
Makara J. Sci.

singlet peak at 1.56 ppm (3H, s). Some impurities at δ
0.88 ppm from silicon grease were also observed. The
results of NMR analysis are consistent with previously
reported data [7,8].
The solubility test, calculated as log P, was performed
using the shake-flask method with n-octanol and water
as partitioning system [17]. The distributions of 3a and
3b in the n-octanol/water system were determined by
HPLC. n-Octanol is generally used as a model solvent
to understand the partitioning of compounds from water
into lipid membranes [19]. The log P values of 3a and
3b are shown in Table 2. The results showed a slightly
higher log P value for 3a than that for TQ. Compound
3b has the highest log P value among the other
compounds; thus, the order of solubility is 3b > 3a >
TQ. The comparison of the log P calculation using the
ALOGPS 2.1 program [20] and the in vitro analysis
(HPLC method) indicated that the order of solubility is
the same. Thus, the increase in alkyl substituent
concomitantly increases the solubility of the compound
in the n-octanol phase. These results follow Lipinski’s rule
of five, i.e., the log P value for the oral administration
of drug candidates is not more than 5 [21]. Two main
factors can rationalize the effect of alkyl substituent on
the solubility of the compounds in the n-octanol/water
system, i.e., the molecular polarity and the tendency for
hydrogen bonding with the solvents [19].

March 2021  Vol. 25  No. 1
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Figure 3. Structure Determination of Compounds 3a and 3b
Table 1. 1H-NMR Spectral Data of Compounds 3a and 3b
3a
δH (J in Hz)
8.09 (s, 1H)
3.91 (s, 3H, -OCH3)
3.40 (t, 2H, J = 6.4)
2.41 (t, 2H, J = 7.1)
2.02 (s, 3H)
1.85 (m, 2H, J = 6.4, 7.1)
1.56–1.28 (m, 8H J = 7.1, 6.4)

Position
1
2
3
4
5
6
7

Table 2. Solubility Test
Compound
3a
3b
TQ

In vitroa
2.22
3.03
2.17

log P
Predictionb
3.64
5.00
2.80

a) HPLC analysis
b) Predicted using the ALOGPS 2.1 program

Table 3. In silico data of 3a, 3b, and TQ with TSPO and
PTEN macromolecule models
Macromolecules Ligand
TSPO

PTEN

3a
3b
TQ
3a
3b
TQ

∆Go
(kcal/mol)
−5.52
−5.21
−5.88
−5.07
−4.59
−4.77

Ki
(µM)
92.16
157.92
49.02
214.29
434.77
335.29

IC50
(µg/mL)
60.68
117.40
16.10
141.10
323.22
110.11

The activities of 3a, 3b, and TQ were analyzed using in
silico molecular docking. The binding interactions of
3a, 3b, and TQ with TSPO and PTEN macromolecule
models were also evaluated. The data collected from in
silico molecular docking are depicted in Table 3. The
binding energies (∆Go) of 3a, 3b, and TQ with TSPO
varied from −5.21 kcal/mol to −5.88 kcal/mol.
However, the binding energies (∆Go) of 3a, 3b, and TQ
with PTEN were slightly higher than those with TSPO.
All three compounds showed a tendency to inhibit the
macromolecule models because ∆Go has a negative
value. The Ki values (Table 3) of 3a, 3b, and TQ show
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3b
δH (J in Hz)
8.09 (s, 1H)
3.91 (s, 3H, -OCH3)
3.51 (t, 2H, J = 6.4)
2.41 (t, 2H, J = 7.1)
2.43 (s, 3H)
1.85 (m, 2H, J = 6.4, 7.1)
1.29 (m, 14H, J = 7.1, 6.4)

that these compounds have a more robust interaction
with TSPO than with PTEN. Compound 3a has a lower
Ki value than 3b by 1.71-fold, and TQ has a lower Ki
value than 3a by 1.88-fold. The order of inhibition
toward the TSPO ligand is TQ > 3a > 3b. Although
compounds 3a and 3b have lower binding energies than
TQ, the presence of the 7-bromoheptyl substituent in 3a
is more favorable than that of 10-bromodecyl in 3b.
Compound 3b has a longer alkyl substituent than 3a;
however, it does not ensure better inhibition toward the
target macromolecules. The longer alkyl substituent
increased the log P (Table 2); however, it might
suppress the activity [22]. The predicted IC50 values of
3a and 3b supported the order of the Ki value. In
summary, compound 3a exhibited better properties as a
drug candidate than 3b for interaction with the TSPO
macromolecules.
Confirmation of the substrate-binding residues between
ligands 3a and 3b with TSPO and PTEN is shown in
Figure 4. The binding interaction of the amino acid
residue on PTEN-3a and PTEN-3b is less than that on
TSPO-3a and TSPO-3b. This result supports the
prediction that the activities of 3a and 3b with PTEN are
lower than that with TSPO. Further analysis revealed
the hydrogen bonding and van der Waals interaction
between enzyme and substrate, which are the critical
relationships between ligands and macromolecules. The
aromatic quinone ring on 3a has actively interacted with
residue TRP135 with the backbone indole group (Naromatic amino acid), indicating the van der Waals
interaction. Moreover, the carbonyl from quinone is
strongly hydrogen bonded to the peptide chain of the
amino group of TRP50. The hydrophobic nature of
March 2021  Vol. 25  No. 1
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TSPO-3a

TSPO-3b

PTEN-3a

PTEN-3b

Figure 4. Molecular Visualization of the Binding Interaction between Ligand 3a and 3b with TSPO and PTEN

benzyl residues from PHE46 and PHE92 strongly
interacted with the alkyl group from 3a. However,
compared with the interaction of TSPO-3b, no hydrogen
bonding occurred between carbonyl and amino acid
residues from TRP50. The significant interaction is the
van der Waals interaction between alkyl and
hydrophobic residues, such as TRP135, ILE134, and
ALA49. The interaction of quinone with TRP135 in
TSPO-3b has a longer distance (5.94 Å) than TSPO-3a
(4.44 Å). The hydrogen bonding in TSPO-3a with
TRP50 has a relatively close range, i.e.,, 1.52 Å. Thus,
we inferred that these residues were vital to substrate
bonding because of their location within the hydrogen
bonding distance (<3 Å) to the substrate [23]. The
overall result indicated that the addition of an alkyl
residue, i.e., 7-bromoalkyl, to the quinone ring partially
supports solubility and improves the activity with TSPO
as target macromolecule.
Makara J. Sci.

Conclusion
The synthesis of 5-methoxy-1,4-benzoquinone having
bromoheptyl and bromodecyl substituents 3a and 3b
was achieved through the decarboxylation reaction. The
evaluation of its solubility indicated that the bromoalkyl
substituent increased the solubility of compounds in noctanol. The activities of 3a and 3b toward the TSPO
macromolecule indicated that TSPO-3a had a lower
binding energy and IC50 than TSPO-3b. The analysis of
the substrate-binding residue showed that TSPO-3a has
a stronger hydrogen bond with the amino acid residue
than TSPO-3b, indicating that TSPO-3a has better
activity than TSPO-3b. The binding of 3a and 3b
toward PTEN showed a lower interaction than that
toward TSPO. The addition of bromoheptyl and
bromodecyl to the 1,4-benzoquinone ring promotes the
increase in solubility. Thus, the binding of the compound
March 2021  Vol. 25  No. 1
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with TSPO indicated that 3a is a promising compound
for anti-inflammatory drug candidates.
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